Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bonviva Micro-architecture Study in Osteopenia
NCT00545207Phase 3Completed
- Sponsor
- Roche
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibandronate in osteopenia, sponsored by Roche. Status: completed.
02
Drugs
ibandronate
03
Conditions
osteopenia
Beyond the preview
Go deeper on NCT00545207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545207.